231 - RICHARD ROWE COMPETITION

Friday, October 25, 2024

11:00 AM – 12:00 PM PT

Room:114-115

Target Audience: Pediatric cardiologists, Cardiovascular surgeons, Adult congenital heart disease specialists

Co-Chair(s)

Michael Khoury, MD, FRCPC

Pediatric Cardiologist
Stollery Children's Hospital
University of Alberta
Steven Rathgeber, MD

PEDIATRIC CARDIOLOGIST
CCS, CAIC, CPCA
University of British Columbia

The finalists for the 2024 Richard Rowe Competition present their abstract research during this 1-hour session.

At the end of this session participants will be able to:

Highlight top-scoring abstracts from Canadian centers in pediatric and congenital cardiology;
Review the prenatal detection of and risk factors for congenital heart disease; and
Review risk factors for the development and progression of atrioventricular valve regurgitation in atrioventricular septal defects.

11:00 AM – 11:10 AM PT

HIGH HETEROGENEITY IN PRENATAL DETECTION RATES OF SEVERE CONGENTAL HEART DISEASE BETWEEN PHYSICIANS, HOSPITALS AND REGIONS
Presenter: Sara Khalilipalandi, MD MSc – Université de Sherbrooke
11:15 AM – 11:25 AM PT

SANGUINEOUS CARDIOPULMONARY BYPASS PRIME ACCELERATES THE INFLAMMATORY RESPONSE DURING PEDIATRIC CARDIAC SURGERY
Presenter: Joel Bierer, MD – Dalhousie University
11:30 AM – 11:40 AM PT

DETERMINING ANTENATAL RISK FACTORS FOR PROGRESSION AND OUTCOME OF ATRIOVENTRICULAR VALVE REGURGITATION IN PATIENTS WITH ATRIOVENTRICULAR SEPTAL DEFECT
Presenter: Hannah Davidson, MBBS, FRACP (she/her/hers) – Stollery Children's Hospital, University of Alberta
11:45 AM – 11:55 AM PT

META-ANALYSIS OF PRENATAL RISK FACTORS FOR CONGENITAL HEART DISEASE: PART 2 - MATERNAL ALCOHOL AND MEDICATION, ASSISTED REPRODUCTIVE TECHNOLOGIES, AND FAMILIAL AND FETAL FACTORS.
Presenter: Alyssia Lemieux, MD (she/her/hers) – University of Sherbrooke